The ASPREE-fracture Sub-study: Does Daily Low-dose Aspirin Reduce Fracture Risk In Healthy Older Adults?
Funder
National Health and Medical Research Council
Funding Amount
$1,351,150.00
Summary
Disability, mortality and healthcare burden from fractures in older people is a growing problem worldwide. This is despite decades of clinical research, best practice guidelines and advances in therapies that aim to reduce fracture risk. The World Health Organization has identified fracture prevention as a public health priority. This study will determine whether a widely available, simple and inexpensive health intervention—aspirin—can reduce the incidence of fracture and associated disability ....Disability, mortality and healthcare burden from fractures in older people is a growing problem worldwide. This is despite decades of clinical research, best practice guidelines and advances in therapies that aim to reduce fracture risk. The World Health Organization has identified fracture prevention as a public health priority. This study will determine whether a widely available, simple and inexpensive health intervention—aspirin—can reduce the incidence of fracture and associated disability amongst older Australians.Read moreRead less
Clinical Approaches To Preventing Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
Cardiovascular disease (CVD) is the leading cause of death and disease burden globally. While many new treatments have been discovered in the last few decades to prevent CVD, surveys show many people do not receive these treatments. Dr. Chow is committed to using her skills as a cardiologist and a researcher to bridge this gap. Her program aims to identify novel, simple and scalable approaches to decrease the gap in preventative care and reduce the burden of CVD in Australia and beyond.
Improving Prevention Of Cardiovascualr Disease In High Risk Populations
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Heart attack and stroke are the leading causes of death and disease burden globally. While there are highly effective treatments to prevent cardiovascular disease, surveys in Australia and other parts of the world indicate they are not being taken up. This program of research aims to improve prevention in individuals at high risk of heart attack and stroke by developing and testing strategies to increase the use of effective evidence-based treatment therapies.
A Developmental Approach To Suicide Prevention And Related Harm Among Australian Youth
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Suicide among Australian youth is a significant and increasing problem in Australia, and is currently the leading cause of death among those aged 15 - 44 years. Early prevention is critical to reducing morbidity and mortality associated with suicide, yet typically occurs too late to have long-term impact. In order to prevent suicidal risk, this Fellowship will focus on improving evidence-based childhood prevention, as well as risk identification, to increase the timeliness of intervention.
Building The Evidence Base For Suicide Prevention: The Victorian Suicide Register
Funder
National Health and Medical Research Council
Funding Amount
$189,238.00
Summary
This partnership between the Coroners Court of Victoria, the Lifeline Foundation for Suicide Prevention, the University of Melbourne and Monash University will develop and evaluate a suicide register. The register will contain detailed information on those who die and the circumstances surrounding their deaths. This information is not systematically collected elsewhere, and will help prevent future suicides by informing coroners’ recommendations and strengthening the broader evidence base.
Monitoring cardiovascular risk is a major part of the clinical workload both in general practice and specialty areas, but it is an under-researched area, reflected in a general lack of evidence based guidelines. My research will evaluate how to optimise the monitoring of cardiovascular risk both before and after starting treatment. By maximising clinical benefits for patients and minimising unnecessary resource use, my research will benefit patients, clinicians and the community at large.
TRIP Fellowship: Bridging The Evidence Practice Gap In Secondary Prevention In Stroke
Funder
National Health and Medical Research Council
Funding Amount
$146,247.00
Summary
Various medications have been shown to reduce the risk of recurrent vascular disease after stroke. This study aims to improve the frequency of use of these medications in patients discharged from hospital after a stroke.
The Management To Optimise Diabetes And MEtabolic Syndrome Risk Reduction Via Nurse-led Intervention (MODERN) Study
Funder
National Health and Medical Research Council
Funding Amount
$1,445,861.00
Summary
There is increasing recognition of society’s responsibility to provide effective and sustainable health care to the entire population and not just selected parts. This practical study will test the impact of a nurse-led, multidisciplinary prevention program to reduce the risk of future cardiovascular events in middle-aged individuals at a high risk of developing cardiovascular disease (CVD) living in regional Australia.
My work focuses on the prevention of vascular disease. A major aim of mine is to improve outcome after stroke. We can test this by assessing whether individualised management plans provided to people with stroke will improve risk factors. Proper risk factor management reduces the risk of stroke recurrence. I also aim to reduce the burden of vascular disease in disadvantaged settings by finding out what risk factors are important in the development of these diseases in people living in poverty.